Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge and Awareness of Pneumococcal Disease |
13.90; 20.41; 21.43 | — |
| SECONDARY Trust in Pharmacists as Vaccine Providers |
1.79; 1.55; 1.80 | — |
| SECONDARY Activation |
77; 41; 91; 27 | — |
| SECONDARY Satisfaction With PPPP |
69; 3; 1; 1; 116; 70 | — |
| SECONDARY Intervention Cost |
162.43 | — |
| SECONDARY Pharmacist Satisfaction |
18; 1; 1; 19; 1; 0 | — |
Eligibility Criteria
Inclusion Criteria
A. Inclusions for PPVP:
- Age ≥ 50 years old
- Can attend a 1.5-hour session at CIP
- Cognitively intact based on responses to an Abbreviated Mental Test Score (AMTS) of ≥7 (see Appendix for AMTS instrument)
- Can speak and read English at ≥4th grade level as evidenced by ability to read a brief passage
- Access to a telephone
B. Inclusions to receive the optional pneumococcal vaccination:
Patient meets ≥1 of the following criteria for receiving their first pneumococcal vaccination:
- All adults age 65 years and older who have not had the vaccine previously
- Age 50-64 years with any of the following conditions:
- Cigarette smokers age 19 years and older
- Chronic cardiovascular disease (e.g., congestive heart failure, cardiomyopathies; excluding hypertension)
- Chronic pulmonary disease (including COPD and emphysema, and for adults ages 19 years and older, asthma)
- Diabetes mellitus
- Alcoholism
- Chronic liver disease, cirrhosis
- Candidate for or recipient of cochlear implant
- Functional or anatomic asplenia (e.g., sickle cell disease, splenectomy)
- Immunocompromising conditions or on immunosuppressive therapy
- Chronic renal failure or nephrotic syndrome
OR
Patient meets ≥1 of the following criteria for receiving a booster dose of the pneumococcal vaccination:
- Adults age 65 years and older who received their first dose for any indication when they were younger than age 65 years.
- Adults age 50-64 who have not received the vaccine for ≥5 years and have one of the following conditions:
- Functional or anatomic asplenia (including persons with sickle cell disease or splenectomy patients);
- Chronic renal failure (including dialysis patients) or nephrotic syndrome;
- Immunocompromising conditions or on immunosuppressive therapy
Exclusion Criteria
A. Exclusions to the PPVP program: none
B. Exclusions to receiving the optional pneumococcal vaccine:
- Participant has a history of allergic reaction to pneumococcal vaccine
- Participant has a history of allergic reaction to any component of any vaccine
- Participant with moderate or severe illness (these individuals will be advised to speak to their doctor regarding the vaccine)
Data sourced from ClinicalTrials.gov (NCT01944462). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.